GW Pharmaceuticals
GWPH
#2624
Rank
A$9.64 B
Marketcap
A$310.03
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for GW Pharmaceuticals (GWPH)

Revenue in 2021 (TTM): A$0.76 Billion

According to GW Pharmaceuticals 's latest financial reports the company's current revenue is A$0.79 Billion. In 2020 the company made a revenue of A$0.74 Billion an increase over the revenue in the year 2019 that were of A$0.43 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for GW Pharmaceuticals from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)A$0.76 B1.9%
2020A$0.74 B69.76%
2019A$0.43 B
2017A$22.68 M41.11%
2016A$16.07 M-68.09%
2015A$50.37 M-26.11%
2014A$68.17 M-0.92%
2013A$68.8 M-10.3%
2012A$76.7 M